Circio logoCircio logo

  • About
      • About Circio
      • CEO Statement
      • Pipeline
      • Management Team
      • Board of Directors
      • Careers
      • The Norwegian Transparency Act
  • circRNA
      • Circio AB
      • circVec platform
  • Clinical programs
      • KRAS program
      • Publications
  • Partnering
  • Investors
      • Press releases
      • Events
      • Financial calendar
      • Reports
      • Presentations
      • Prospectus
      • Share facts
      • Largest shareholders
      • Dividend policy
      • Analyst coverage
      • Registrar and auditor
      • Corporate Governance Policy
      • Code of Conduct
      • Corporate Social Responsibility Principles
      • Remuneration Principles
      • About General Meeting
        • General Meetings
      • Articles of Association
      • Board of Directors
        • Nomination Committee
        • Committees
      • Management
      • Contact
  • Media
      • Press releases
      • Events
      • Subscribe
      • Contact
  • Contacts
    • About
      • About Circio
      • CEO Statement
      • Our pipeline
      • Management Team
      • Board of Directors
      • Careers
      • The Norwegian Transparency Act
    • circRNA
      • Circio AB
      • circVec platform
    • Clinical programs
      • KRAS program
      • Publications
    • Partnering
      • Partnering
    • Investors
      • Warrants exercise 2024
      • Press releases
      • Events
      • Financial calendar
      • Reports
      • Presentations
      • Prospectus
      • Share information
        • Share and trading information
        • Largest shareholders
        • Dividend policy
        • Analyst coverage
        • Registrar and auditor
      • Corporate Governance Policy
      • Code of Conduct
      • Corporate Social Responsibility Principles
      • Remuneration Principles
      • About General Meeting
      • General Meetings
      • Articles of Association
      • Board of Directors
      • Nomination Committee
      • Committees
      • Management
      • Contact
    • Media
      • Press releases
      • Events
      • Subscribe
      • Contact
    • Contacts
      • Offices
      • Investors & Media
    Press releases - Non-regulatory
    • Press releases - Regulatory
    • All press releases
    2023
    • 2026
    • 2025
    • 2024
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    All subjects
    • Corporate news
    • Other
    All languages
    • English
    • Norwegian
    November 29, 2023
    Press release - Non-regulatory

    Reminder: Circio invites to circular RNA R&D webinar today

    November 24, 2023
    Press release - Non-regulatory

    Circio announces outcome of TG01/gemcitabine combination EU patent proceeding

    November 16, 2023
    Press release - Non-regulatory

    Circio inngår nytt samarbeid i USA for å teste kreftvaksinen TG01 i RAS-mutert kreft

    November 16, 2023
    Press release - Non-regulatory

    Circio joins collaboration to test the combination of TG01 vaccination with daratumumab and nivolumab in immunotherapy resistant patients with mutant RAS cancers

    November 9, 2023
    Press release - Non-regulatory

    Circio invites to circular RNA R&D webinar Wednesday 29 November 2023

    October 26, 2023
    Press release - Non-regulatory

    Circio presents powerful expression data for new generation circVec 2.0 design at the ESGCT 2023 annual meeting

    October 19, 2023
    Press release - Non-regulatory

    Circio: circRNA poster to be presented at the 30th European Society for Gene and Cell Therapy (ESGCT)

    October 10, 2023
    Press release - Non-regulatory

    Circio and Neoregen Biotech enter collaboration for delivery of novel circular RNA therapeutics using NICT technology

    October 4, 2023
    Press release - Non-regulatory

    Circio invites to a company update on Wednesday 11 October 2023

    September 25, 2023
    Press release - Non-regulatory

    Circio: circRNA poster to be presented at the 15th international adenovirus meeting

    September 7, 2023
    Press release - Non-regulatory

    Circio invites to Q&A webcast regarding Extraordinary General Meeting

    September 4, 2023
    Press release - Non-regulatory

    ONCOS-102 mesothelioma study published in Journal for ImmunoTherapy of Cancer

    August 15, 2023
    Press release - Non-regulatory

    Circio Holding ASA: Invitation to Circio’s first half year 2023 presentation, Thursday 24 August

    June 22, 2023
    Press release - Non-regulatory

    Circio: Første pasient med benmargskreft dosert med TG01 i studie på Oslo Universitetssykehus

    June 22, 2023
    Press release - Non-regulatory

    Circio: First patient in multiple myeloma trial dosed with TG01 at Oslo University Hospital

    June 15, 2023
    Press release - Non-regulatory

    Circio Holding ASA: June 2022 company update

    May 31, 2023
    Press release - Non-regulatory

    Circio invites to a company update on Thursday 15 June 2023

    May 16, 2023
    Press release - Non-regulatory

    Circio: Link to recording and presentation from Company update 16[th] May 2023

    May 3, 2023
    Press release - Non-regulatory

    Circio: circRNA poster to be presented at the ASGCT Annual Meeting

    March 15, 2023
    Press release - Non-regulatory

    Targovax ASA: circRNA poster to be presented at the AACR Annual Meeting

    March 14, 2023
    Press release - Non-regulatory

    Targovax: First patient dosed with TG01 in the USA

    IR contact
    Dr Erik Digman Wiklund
    Dr Erik Digman Wiklund
    CEO
    erik.wiklund@circio.com
    (+47) 41 33 35 36
    Dr Lubor Gaal
    Dr Lubor Gaal
    CFO & Head of BD
    lubor.gaal@circio.com
    (+34) 683 343 811
    Circio logo

    Circio Holding ASA is a biotechnology company developing novel circular RNA and immunotherapy medicines.

    • About
    • circRNA
    • Clinical programs
    • Partnering
    • Investors
    • Media
    • Contacts

    CONTACT

    Circio Holding ASA
    Email: contact@circio.com

    • Cookies
    • Privacy policy
    • STAY CONNECTED